Mark Keller
5Patents
2h-index
11Co-inventors
40Inventor score
Filing activity: Feb 22, 2013 → Feb 13, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9738697B2 | Alpha/beta-polypeptide analogs of glucagon-like peptide-1 | Human Necessities | 2 | Active |
| US10376563B1 | Methods for systemically delivering polypeptides and microorganisms therefor | Chemistry; Metallurgy | 2 | Active |
| US9381176B2 | E-prostanoid receptor, Ptger3, as a novel anti-diabetic therapeutic target | Human Necessities | 0 | Active |
| US11427569B2 | Benzoimidazole indolyl methanes and methods of using them to inhibit PCKS9 and PCKS9-mediated ailments | Chemistry; Metallurgy | 0 | Active |
| US10723779B2 | Alpha/beta-polypeptide analogs of glucagon-like peptide 1 | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.